Use of nasal continuous positive airway pressure to treat severe recurrent apnoea in very preterm infants.
Nasal continuous positive airway pressure (C.P.A.P.) of 2-3 mm Hg abolished or reduced the incidence of severe apnoeic attacks in 5 very preterm newborn infants. It is postulated that C.P.A.P. provides a respiratory drive by reflexly stimulating the infant's pulmonary stretch receptors.
D001049:Apnea / Q000209:etiology / Q000628:therapy*; D001724:Birth Weight; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008991:Monitoring, Physiologic; D009305:Nasopharynx; D011175:Positive-Pressure Respiration / Q000379:methods*; D012008:Recurrence; D012127:Respiratory Distress Syndrome, Newborn / Q000150:complications / Q000628:therapy*